GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
86 hedge funds and large institutions have $47.5M invested in GALENA BIOPHARMA INC COM in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 11 closing their positions.
84% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 19
23% more call options, than puts
Call options by funds: $6.18M | Put options by funds: $5.01M
6% more capital invested
Capital invested by funds: $44.9M → $47.5M (+$2.56M)
9% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 11
1% less funds holding
Funds holding: 87 → 86 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$846K |
| 2 |
Group One Trading
Chicago,
Illinois
|
+$705K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$602K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$583K |
| 5 |
State Street
Boston,
Massachusetts
|
+$449K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.78M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$3.48M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.66M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$675K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$348K |
RXII Hedge Fund Activity: Q2 2015 in Review
86 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q2 2015, worth a combined $47.5M — up 5.7% from $44.9M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of RXII and 10 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 35 added.
The largest buyer was Vanguard Group, adding an estimated $846K. The largest seller was Sabby Management, exiting entirely with an estimated $4.78M sold.
- 86 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q2 2015, down from 87 in Q1 2015.
- Funds reported $47.5M of GALENA BIOPHARMA INC COM stock for Q2 2015, up 5.7% quarter-over-quarter.
- 10 funds opened new GALENA BIOPHARMA INC COM positions in Q2 2015 and 11 closed out, a net change of -1 holder.
- The largest GALENA BIOPHARMA INC COM buyer in Q2 2015 was Vanguard Group, an estimated $846K added.
- The largest GALENA BIOPHARMA INC COM seller in Q2 2015 was Sabby Management, an estimated $4.78M sold.
Based on aggregated 13F filings for Q2 2015.